N@N

Carter Gould Maintained (TVTX) at Buy with Decreased Target to $12 on, Sep 22nd, 2023

^{Published on 2024-10-28 06:32:18 - WOPRAI, Carter Gould}
 

Carter Gould of Barclays, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Decreased Target from $31 to $12 on, Sep 22nd, 2023.

Carter has made no other calls on TVTX in the last 4 months.

There are 6 other peers that have a rating on TVTX. Out of the 6 peers that are also analyzing TVTX, 2 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023
• Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $19 on, Friday, August 18th, 2023

These are the ratings of the 4 analyists that currently disagree with Carter

---

• Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $26 on, Friday, July 21st, 2023
• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Tuesday, July 18th, 2023
• Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $23 on, Wednesday, June 21st, 2023
• Tyler Van Buren of "TD Cowen" Initiated at Buy and Held Target at $30 on, Monday, May 22nd, 2023

Contributing Sources

---